{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:40:49Z","timestamp":1788435649864,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005029","name":"Helse Vest Regionalt Helsef\u00f8retak","doi-asserted-by":"publisher","award":["F-12625"],"award-info":[{"award-number":["F-12625"]}],"id":[{"id":"10.13039\/501100005029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.pan.2024.12.018","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T02:26:52Z","timestamp":1735180012000},"page":"367-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Patient-derived organoids from pancreatic cancer after pancreatectomy: Feasibility and organoid take rate in treatment-na\u00efve periampullary tumors"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4689-4412","authenticated-orcid":false,"given":"Marcus T.T.","family":"Roals\u00f8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Alexeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Oan\u00e6s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9681-7805","authenticated-orcid":false,"given":"Martin","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7098-3098","authenticated-orcid":false,"given":"Dordi","family":"Lea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Zaharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne R.","family":"Hagland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7594-4354","authenticated-orcid":false,"given":"Kjetil","family":"S\u00f8reide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pan.2024.12.018_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.pan.2024.12.018_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.741162","article-title":"Pancreatic ductal adenocarcinoma: preclinical in vitro and ex vivo models","volume":"9","author":"G\u00fcndel","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.pan.2024.12.018_bib3","first-page":"910","article-title":"2D and 3D cell cultures - a comparison of different types of cancer cell cultures","volume":"14","author":"Kapalczynska","year":"2018","journal-title":"Arch Med Sci"},{"issue":"1","key":"10.1016\/j.pan.2024.12.018_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40170-022-00285-w","article-title":"Metabolic flux analysis of 3D spheroids reveals significant differences in glucose metabolism from matched 2D cultures of colorectal cancer and pancreatic ductal adenocarcinoma cell lines","volume":"10","author":"Tidwell","year":"2022","journal-title":"Cancer Metabol"},{"issue":"11","key":"10.1016\/j.pan.2024.12.018_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7318","article-title":"Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using 2D and 3D cell models: contrasting viability and growth inhibition in clinically relevant dose and repeated drug cycles","volume":"13","author":"Tidwell","year":"2024","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.pan.2024.12.018_bib6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/MPA.0000000000002084","article-title":"Organoids: a promising preclinical model for pancreatic cancer research","volume":"51","author":"Navarro-Serer","year":"2022","journal-title":"Pancreas"},{"issue":"1\u20132","key":"10.1016\/j.pan.2024.12.018_bib7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","article-title":"Organoid models of human and mouse ductal pancreatic cancer","volume":"160","author":"Boj","year":"2015","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.pan.2024.12.018_bib8","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/nm.3973","article-title":"Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids","volume":"21","author":"Huang","year":"2015","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.pan.2024.12.018_bib9","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/jgh.15930","article-title":"Patient-derived cancer organoids for drug screening: basic technology and clinical application","volume":"37","author":"Ren","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"issue":"15","key":"10.1016\/j.pan.2024.12.018_bib10","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1158\/1078-0432.CCR-21-4165","article-title":"Precision medicine in pancreatic cancer: patient-derived organoid pharmacotyping is a predictive biomarker of clinical treatment response","volume":"28","author":"Sepp\u00e4l\u00e4","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pan.2024.12.018_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-023-02790-x","article-title":"Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma","author":"Jiang","year":"2024","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.pan.2024.12.018_bib12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/path.5684","article-title":"Organoids in cancer research: a review for pathologist-scientists","volume":"254","author":"Wood","year":"2021","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.pan.2024.12.018_bib13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1158\/1078-0432.CCR-20-4116","article-title":"Organoid sensitivity correlates with therapeutic response in patients with pancreatic cancer","volume":"28","author":"Grossman","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.pan.2024.12.018_bib14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/path.5906","article-title":"Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment","volume":"257","author":"Hennig","year":"2022","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.pan.2024.12.018_bib15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12885-022-09619-9","article-title":"Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer","volume":"22","author":"Watanabe","year":"2022","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.pan.2024.12.018_bib16","doi-asserted-by":"crossref","first-page":"E361","DOI":"10.1055\/a-2257-3171","article-title":"Comparison of endoscopic ultrasound-guided fine-needle aspiration and fine-needle biopsy to generate pancreatic cancer organoids: randomized trial","volume":"12","author":"Wiessner","year":"2024","journal-title":"Endosc Int Open"},{"issue":"4","key":"10.1016\/j.pan.2024.12.018_bib17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.5009\/gnl210166","article-title":"Establishment of patient-derived pancreatic cancer organoids from endoscopic ultrasound-guided fine-needle aspiration biopsies","volume":"16","author":"Lee","year":"2022","journal-title":"Gut Liver"},{"issue":"3","key":"10.1016\/j.pan.2024.12.018_bib18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/SLA.0000000000004200","article-title":"Patient-derived organoid pharmacotyping is a clinically tractable strategy for precision medicine in pancreatic cancer","volume":"272","author":"Sepp\u00e4l\u00e4","year":"2020","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.pan.2024.12.018_bib19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/SLA.0000000000005558","article-title":"Pancreatic cancer patient-derived organoids can predict response to neoadjuvant chemotherapy","volume":"276","author":"Demyan","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.pan.2024.12.018_bib20","article-title":"Isolation and characterization of patient-derived pancreatic ductal adenocarcinoma organoid models","volume":"155","author":"Tiriac","year":"2020","journal-title":"J Vis Exp"},{"key":"10.1016\/j.pan.2024.12.018_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1327772","article-title":"Hypoxia at 3D organoid establishment selects essential subclones within heterogenous pancreatic cancer","volume":"12","author":"Kumano","year":"2024","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.pan.2024.12.018_bib22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jamcollsurg.2020.11.009","article-title":"Development of a single-cell technique to increase yield and use of gastrointestinal cancer organoids for personalized medicine application","volume":"232","author":"Gao","year":"2021","journal-title":"J Am Coll Surg"},{"issue":"3","key":"10.1016\/j.pan.2024.12.018_bib23","article-title":"Establishment of pancreatic organoids from normal tissue and tumors","volume":"1","author":"Driehuis","year":"2020","journal-title":"STAR Protoc"},{"issue":"10","key":"10.1016\/j.pan.2024.12.018_bib24","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1038\/s41596-020-0379-4","article-title":"Establishment of patient-derived cancer organoids for drug-screening applications","volume":"15","author":"Driehuis","year":"2020","journal-title":"Nat Protoc"},{"key":"10.1016\/j.pan.2024.12.018_bib25","series-title":"Digestive system tumours","first-page":"635","article-title":"International agency for research on C","author":"Lokuhetty","year":"2019"},{"key":"10.1016\/j.pan.2024.12.018_bib26","series-title":"American Joint Committee on C. AJCC cancer staging manual","first-page":"1032","author":"Amin","year":"2017"},{"issue":"1","key":"10.1016\/j.pan.2024.12.018_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12885-018-4238-4","article-title":"Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models","volume":"18","author":"Tsai","year":"2018","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.pan.2024.12.018_bib28","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","article-title":"Organoid profiling identifies common responders to chemotherapy in pancreatic cancer","volume":"8","author":"Tiriac","year":"2018","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.pan.2024.12.018_bib29","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/jcsm.12627","article-title":"Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia","volume":"11","author":"Vaes","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.pan.2024.12.018_bib30","article-title":"Deep molecular characterization linked to drug response profiling of pancreatic ductal adenocarcinoma using patient-derived organoids","volume":"2021.08.26","author":"Blanc","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.pan.2024.12.018_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-8879-2_9","article-title":"Generation and culture of human pancreatic ductal adenocarcinoma organoids from resected tumor specimens","volume":"1882","author":"Baker","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"52","key":"10.1016\/j.pan.2024.12.018_bib32","doi-asserted-by":"crossref","first-page":"26580","DOI":"10.1073\/pnas.1911273116","article-title":"Pancreatic cancer organoids recapitulate disease and allow personalized drug screening","volume":"116","author":"Driehuis","year":"2019","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"22","key":"10.1016\/j.pan.2024.12.018_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158060","article-title":"Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers","volume":"7","author":"Hogenson","year":"2022","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.pan.2024.12.018_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112539","article-title":"A prospective feasibility trial to challenge patient-derived pancreatic cancer organoids in predicting treatment response","volume":"13","author":"Beutel","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.pan.2024.12.018_bib35","article-title":"CFTR expression analysis for subtyping of human pancreatic cancer organoids","volume":"2019","author":"Hennig","year":"2019","journal-title":"Stem Cell Int"},{"issue":"2","key":"10.1016\/j.pan.2024.12.018_bib36","article-title":"Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatment","volume":"2","author":"Hirt","year":"2022","journal-title":"Cell Genom"},{"key":"10.1016\/j.pan.2024.12.018_bib37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fonc.2020.00553","article-title":"Metabolic heterogeneity in patient tumor-derived organoids by primary site and drug treatment","volume":"10","author":"Sharick","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.pan.2024.12.018_bib38","series-title":"Multi-drug pharmacotyping improves therapy prediction in pancreatic cancer organoids","author":"Wansch","year":"2024"},{"issue":"10","key":"10.1016\/j.pan.2024.12.018_bib39","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1038\/s41401-022-00897-4","article-title":"Pan-KRAS inhibitors suppress proliferation through feedback regulation in pancreatic ductal adenocarcinoma","volume":"43","author":"Wang","year":"2022","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/j.pan.2024.12.018_bib40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13046-022-02519-7","article-title":"Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system","volume":"41","author":"Schuth","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.pan.2024.12.018_bib41","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s13402-024-00939-5","article-title":"Establishment, characterization, and biobanking of 36 pancreatic cancer organoids: prediction of metastasis in resectable pancreatic cancer","volume":"47","author":"Kim","year":"2024","journal-title":"Cell Oncol"},{"issue":"5","key":"10.1016\/j.pan.2024.12.018_bib42","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1053\/j.gastro.2024.05.032","article-title":"Organoids for functional precision medicine in advanced pancreatic cancer","volume":"167","author":"Boileve","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pan.2024.12.018_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.semcancer.2024.09.002","article-title":"Unravelling the complexities of resistance mechanism in pancreatic cancer: insights from in vitro and ex-vivo model systems","volume":"106\u2013107","author":"Lencioni","year":"2024","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.pan.2024.12.018_bib44","article-title":"Organoid-based precision medicine in pancreatic cancer","author":"Beutel","year":"2024","journal-title":"United European Gastroenterol J"},{"issue":"12","key":"10.1016\/j.pan.2024.12.018_bib45","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.ccell.2023.11.007","article-title":"Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites","volume":"41","author":"Dayton","year":"2023","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.pan.2024.12.018_bib46","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.cell.2020.10.023","article-title":"An organoid biobank of neuroendocrine neoplasms enables genotype-phenotype mapping","volume":"183","author":"Kawasaki","year":"2020","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pan.2024.12.018_bib47","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.gendis.2023.02.052","article-title":"Cancer organoids: a platform in basic and translational research","volume":"11","author":"Ma","year":"2024","journal-title":"Genes Dis"},{"issue":"1","key":"10.1016\/j.pan.2024.12.018_bib48","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12967-016-0951-4","volume":"14","author":"Soreide","year":"2016","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.pan.2024.12.018_bib49","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","article-title":"Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium","volume":"141","author":"Sato","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.pan.2024.12.018_bib50","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.stem.2021.04.005","article-title":"Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids","volume":"28","author":"Marsee","year":"2021","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.pan.2024.12.018_bib51","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41374-020-00494-1","article-title":"Establishing a living biobank of patient-derived organoids of intraductal papillary mucinous neoplasms of the pancreas","volume":"101","author":"Beato","year":"2021","journal-title":"Lab Invest"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390324008469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390324008469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:00:27Z","timestamp":1762545627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390324008469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1424390324008469"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2024.12.018","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-derived organoids from pancreatic cancer after pancreatectomy: Feasibility and organoid take rate in treatment-na\u00efve periampullary tumors","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2024.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of IAP and EPC.","name":"copyright","label":"Copyright"}]}}